secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001725160-25-000108
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zentalis to present at three investor conferences in May-June 2025
------------------------------------------------------------------

- H.C. Wainwright BioConnect Conference – May 20, 2025, at 11:30 a.m. ET in New York, NY.
- TD Cowen Oncology Innovation Summit – May 27, 2025, at 11:00 a.m. ET (virtual).
- Jefferies Healthcare Conference – June 4, 2025, at 9:55 a.m. ET in New York, NY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516025000108/0001725160-25-000108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516025000108/zntl-20250520.htm
  HTML page:      https://secwatch.observer/filing/0001725160-25-000108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer